01—Abstract
Summary
Summary of the 8-K filed May 7, 2026. Cited figures are marked; the original filing is the authoritative source.
Rocket Lab (RKLB) reported first-quarter 2026 results that management characterized as a record quarter across revenue, gross margin, and backlog.
Revenue reached $200.3Ma, up 63.5% year over year from $122.6M, and GAAP gross margin expanded to 38.2% (from roughly 28.8% a year earlier). GAAP operating loss narrowed to $55.97M from $59.19M, and net loss improved to $45.0M, or $(0.07) per share, versus $60.6M, or $(0.12), in Q1 2025. Adjusted EBITDA was $(11.8)M, compared with $(30.0)M a year earlier.
Backlog rose 20.2% quarter over quarter to $2.2Bb, and the company cited more than $2B of total liquidity following an at-the-market equity program. The balance sheet strengthened substantially: cash and equivalents rose to $1.21B from $829M, largely from $450M of ATM equity proceeds, and the convertible senior notes fell to $36.9M from $152.4M, likely reflecting conversion or repayment. Operating cash flow was still negative at $(50.3)M, and inventories, receivables, and contract assets all grew, so working-capital needs are rising alongside growth.
Share count increased as well, with outstanding common shares rising to about 576M from 544M. Looking ahead, management guided Q2 2026 revenue to $225c–240M, GAAP gross margin to 33–35%, and adjusted EBITDA loss to $20–26M. The guidance implies lower GAAP gross margin than Q1 and a wider EBITDA loss, which investors will likely scrutinize.
Key strategic items include the Mynaric acquisition (closed), a pending Motiv acquisition, selection for the Space Based Interceptor program under Golden Dome, and the Neutron medium-lift rocket's targeted debut later in 2026. Neutron timing and margin trajectory remain the central execution risks.
02—Key points
Key Highlights
- Record Q1 2026 revenue of $200.3M, up 63.5% YoY; GAAP gross margin hit a record 38.2%, with non-GAAP gross margin at 43.0%.
- Net loss narrowed to $45.0M ($0.07 per share) from $60.6M ($0.12 per share) a year earlier; adjusted EBITDA improved to $(11.8)M from $(30.0)M.
- Backlog reached a record $2.2B, up 20.2% QoQ; 31 new Electron and HASTE contracts and five new dedicated Neutron launches were signed in Q1.
- Cash and equivalents rose to $1.21B from $829M, driven by $450M of ATM equity proceeds; convertible notes declined to $36.9M from $152.4M.
- Operating cash flow remained negative at $(50.3)M, with receivables, inventories, and contract assets all rising, indicating heavy working-capital investment.
- Q2 2026 guidance calls for revenue of $225–240M, GAAP gross margin of 33–35% (below Q1), and an adjusted EBITDA loss of $20–26M.
- Strategic progress includes Mynaric acquisition closing, a pending Motiv acquisition, selection for the Golden Dome Space Based Interceptor program, and Neutron's targeted debut later in 2026.
03—Questions
Frequently Asked Questions
How did Rocket Lab's Q1 2026 revenue and profitability compare with a year earlier?
Revenue grew 63.5% to $200.3M from $122.6M. GAAP gross profit rose to $76.5M from $35.2M, and the net loss narrowed to $45.0M from $60.6M. The company remains unprofitable on a GAAP basis, but losses are shrinking as a share of revenue.
Why is Q2 2026 guidance showing lower gross margins than Q1?
The filing guides Q2 GAAP gross margin to 33–35%, versus 38.2% in Q1, and does not explain the drivers in this document. Investors should review the earnings call for management's explanation, which may relate to program mix, ramp costs, or acquisition effects.
How strong is Rocket Lab's liquidity after the recent equity raise?
Cash and equivalents increased to $1.21B, and marketable securities totaled about $271M (current plus non-current). Management cites over $2B in total liquidity, including undrawn access. Equity raises increased the share count to about 576M outstanding, which dilutes existing holders.
What does the $2.2B backlog mean for future revenue?
The record backlog, up 20.2% QoQ, supports visibility into future revenue across launch and space systems. Contract liabilities (customer prepayments) also rose to $241M, supporting near-term cash collection, though backlog conversion timing is not specified in this filing.
What are the main near-term catalysts and risks?
Catalysts include the Neutron medium-lift rocket's debut targeted for later in 2026, the Golden Dome Space Based Interceptor role, and the pending Motiv acquisition. Risks include Neutron development delays, continued negative operating cash flow, margin pressure, and dilution from ongoing equity issuance.
04—Continue